INS and fatty liver disease: Insulin resistance is one of the most important factors in the development of hepatic steatosis, however, pharmacological treatment related to insulin-sensitizing agents (metformin and thiazolidinediones [TZDs]) has been studied in hepatic steatosis with conflicting results in clinical situations [8].